A Real-World Study of Cerebral 99mTc-TRODAT-1 Single-Photon Emission Computed Tomography (SPECT) Imaging of the Dopamine Transporter in Patients with Parkinson Disease from a Tertiary Hospital in Brazil

Michelly Arjona; Juliana M.P. Toldo; Natalia Carvalho Queiroz; Jose Luiz Pedroso; Guilherme de Carvalho Campos Neto; Orlando G.P. Barsottini; Andre C. Felicio

doi:10.12659/MSM.925130

23 December 2020 : Clinical Research

A Real-World Study of Cerebral 99mTc-TRODAT-1 Single-Photon Emission Computed Tomography (SPECT) Imaging of the Dopamine Transporter in Patients with Parkinson Disease from a Tertiary Hospital in Brazil

Michelly Arjona^1CDEF, Juliana M.P. Toldo^1BCDEF, Natalia Carvalho Queiroz^1ABCD, Jose Luiz Pedroso^2ACD, Guilherme de Carvalho Campos Neto^2ACD, Orlando G.P. Barsottini^2ACD, Andre C. Felicio^1ABCDEF*

DOI: 10.12659/MSM.925130

Med Sci Monit 2020; 26:e925130

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Suitability of brain scintigraphy with 99m Tc-TRODAT-1 requests. Indications that suggested intergroup disease (degenerative parkinsonism versus non-degenerative conditions) were considered appropriate.

Degenerative parkinsonism	Non-degenerative conditions
Parkinson’s disease	Essential tremor
Atypical parkinsonism	Psychogenic parkinsonism
Lewy body dementia	Vascular parkinsonism
Others^*	Drug-induced parkinsonism
	Others^*
^* Analyzed case by case.

Back to the Article

A Real-World Study of Cerebral 99mTc-TRODAT-1 Single-Photon Emission Computed Tomography (SPECT) Imaging of the Dopamine Transporter in Patients with Parkinson Disease from a Tertiary Hospital in Brazil

Your Privacy